Sonia Pernas Selected Research

Sonia Pernas Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2010
28	Neoplasms (Cancer) 12/2023 - 09/2013
5	Triple Negative Breast Neoplasms 12/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 06/2023 - 11/2019
3	Pathologic Complete Response 01/2022 - 01/2020
3	Residual Neoplasm 12/2019 - 01/2019
2	Carcinoma (Carcinomatosis) 11/2020 - 09/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 01/2016
2	Ductal Carcinoma 11/2018 - 11/2005
2	Inflammation (Inflammations) 11/2018 - 07/2018
2	Neoplasm Micrometastasis 01/2018 - 03/2010
1	Heart Diseases (Heart Disease) 12/2023
1	Lymphedema (Milroy Disease) 01/2023
1	Disease Progression 01/2023
1	Inflammatory Breast Neoplasms 01/2022
1	COVID-19 01/2021
1	Cardiotoxicity 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Margins of Excision 11/2018
1	Infections 11/2018
1	Insulin Resistance 07/2018
1	Overweight 07/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2009
1	Lung Neoplasms (Lung Cancer) 10/2009
1	Febrile Neutropenia 10/2009
1	Cicatrix (Scar) 11/2005
1	Hemangiosarcoma (Angiosarcoma) 11/2005

Drug/Important Bio-Agent (IBA)

14	Trastuzumab (Herceptin)FDA Link 01/2021 - 08/2012
9	Hormones (Hormone)IBA 03/2024 - 01/2018
7	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2017
6	Metformin (Glucophage)FDA LinkGeneric 02/2022 - 09/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 08/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
4	human ERBB2 proteinIBA 01/2022 - 12/2018
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2018
3	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2019
3	Estrogen ReceptorsIBA 11/2020 - 01/2018
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2024 - 01/2018
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2020
2	Insulin (Novolin)FDA Link 02/2022 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2020
2	Lapatinib (GW572016)FDA Link 01/2021 - 01/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 08/2012
2	pertuzumabIBA 01/2021 - 12/2019
2	eribulin FDA Link 11/2019 - 01/2018
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2018 - 03/2017
2	taxaneIBA 01/2017 - 01/2016
1	pembrolizumabIBA 11/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	1-dodecylpyridoxal (PLD)IBA 01/2021
1	patritumab deruxtecanIBA 01/2021
1	RANK LigandIBA 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	AnthracyclinesIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	palbociclibIBA 11/2020
1	ribociclibIBA 12/2019
1	Cyclin-Dependent Kinase 4IBA 12/2019
1	Ado-Trastuzumab EmtansineIBA 12/2019
1	Dasatinib (BMS 354825)FDA Link 04/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	ParaffinIBA 01/2019
1	CarbonIBA 01/2019
1	HomocysteineIBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Folic Acid AntagonistsIBA 01/2019
1	Keratin-18 (Keratin 18)IBA 11/2018
1	NAD (NADH)IBA 11/2018
1	AdipokinesIBA 07/2018
1	LeptinIBA 07/2018
1	AdiponectinIBA 07/2018
1	balixafortideIBA 01/2018
1	Retinoblastoma ProteinIBA 01/2018
1	EnzymesIBA 01/2018
1	Cyclin DIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2017
1	Taxoids (Taxanes)IBA 01/2017
1	PlatinumIBA 01/2016
1	MicronutrientsIBA 01/2016
1	Prealbumin (Transthyretin)IBA 01/2016
1	TOR Serine-Threonine KinasesIBA 09/2013
1	Phosphotransferases (Kinase)IBA 09/2013
1	Fluorouracil (Carac)FDA LinkGeneric 08/2012

Therapy/Procedure

25	Therapeutics 03/2024 - 03/2010
14	Drug Therapy (Chemotherapy) 06/2023 - 11/2005
12	Neoadjuvant Therapy 04/2024 - 03/2017
5	Radiotherapy 06/2023 - 11/2005
5	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 11/2005
3	Immunotherapy 12/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2022 - 11/2005
1	Adjuvant Chemotherapy 01/2020
1	Segmental Mastectomy (Lumpectomy) 11/2018
1	Radiofrequency Ablation 11/2018
1	Precision Medicine 02/2015
1	Diet Therapy (Therapy, Diet) 09/2013
1	Simple Mastectomy 11/2005
1	Mastectomy (Mammectomy) 11/2005